Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment

Cytokine
Hyo Jung ChoSung Won Cho

Abstract

We aimed to investigate the use of novel serum biomarkers for predicting the recurrence and survival of patients with hepatitis B virus (HBV)-related early hepatocellular carcinoma (HCC) after hepatic resection or radiofrequency ablation (RFA). One hundred and five patients with HBV-related HCC, who fulfilled the Milan criteria without vascular invasion and underwent hepatic resection or RFA, were followed-up for a median duration of 52months. Pretreatment serum concentrations of 16 cytokines including interleukin-6 (IL-6) were measured by using a Luminex 200 system. The measured serum cytokines and several clinical factors were analyzed retrospectively. Univariate analysis showed that patients with lower pretreatment serum levels of IL-10, IL-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α had significantly shorter disease-free survival (DFS) than those with higher levels. Multivariate analysis revealed that a low serum IL-6 level (⩽33.00pg/mL; hazard ratio [HR]=5.39; 95% confidence interval [CI]=1.27-22.93; P=0.022), low platelet count (<100×10(9)/L; HR=2.23; 95% CI=1.28-3.89; P=0.005), and low serum albumin level (⩽3.5g/L; HR=2.26; 95% CI=1.28-3.97; P=0.005) had a negative prognostic impact on DFS. In the ...Continue Reading

References

Mar 23, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Diarmuid M MoranIain H McKillop
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zia A DehqanzadaGeorge E Peoples
Jun 1, 2006·Familial Cancer·W Martin Howell, Matthew J Rose-Zerilli
Feb 17, 2007·International Journal of Cancer. Journal International Du Cancer·Kwong-Ming KeeSheng-Nan Lu
Oct 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C PortaG R Corazza
Apr 5, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Katriina HeikkiläDebbie A Lawlor
Oct 16, 2010·Seminars in Cancer Biology·Ju Dong YangLewis R Roberts
Feb 19, 2011·Omics : a Journal of Integrative Biology·Lydia GiannitrapaniGiuseppe Montalto
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Jun 18, 2011·Critical Reviews in Oncology/hematology·Ashish SinghalVivek Kohli
Sep 24, 2011·Hepato-gastroenterology·Xiong-Hao PangMin-Shan Chen
Oct 19, 2011·International Journal of Hepatology·Cher Heng TanChoon Hua Thng
Aug 1, 2012·Seminars in Oncology·Ryota MasuzakiMasao Omata
Sep 27, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Yafei ZhangZhiguo Rao
Nov 14, 2012·Nature Reviews. Gastroenterology & Hepatology·Roberta W C Pang, Ronnie T P Poon
Sep 6, 2013·Annals of Surgical Oncology·Ioannis HatzarasTimothy M Pawlik
Nov 2, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·You-Bing ZhengBao-Shan Hu
Nov 16, 2013·JAMA Otolaryngology-- Head & Neck Surgery·Nadine M KaskasCherie-Ann O Nathan
Jan 1, 2014·World Journal of Gastroenterology : WJG·Tao LuMan-Fung Yuen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.